Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Public Health Screening topic
No spam. Unsubscribe anytime.
Committee advances HB1042 to align state prostate‑cancer screening with national guidelines
Summary
HB1042, presented by Senator Dave Wallace, updates state law so prostate‑cancer screening references the National Comprehensive Cancer Network guideline; committee members asked about fiscal and Medicaid impacts and the bill passed out of committee.
The Senate Insurance & Commerce Committee voted to advance HB1042, which amends state law to match prostate‑cancer screening language to the National Comprehensive Cancer Network (NCCN) guideline.
Senator Dave Wallace, presenting the bill, told the committee the change "enhances the prostate cancer screening" statute to meet current NCCN guidance and that there is no anticipated physical or fiscal impact. Members asked whether the update would create any reimbursement or Medicaid duties; Wallace said he was not aware of any costs and would confirm if any Medicaid ramifications exist.
Senator Johnson noted Representative Allen — a sponsor with a personal history of prostate cancer — and supported the bill while asking about the bill's prospective language that allows the commissioner to add new clinical recommendations by rule. Wallace said the change provides flexibility to adopt improved screening methods over time.
The committee voted 'do pass' and the chair announced that HB1042 "has passed." The bill will proceed to the next legislative stage.
